Your browser doesn't support javascript.
loading
Extract and molecular-based early infant sensitization and associated factors-A PreventADALL study.
Tedner, Sandra G; Söderhäll, Cilla; Konradsen, Jon R; Bains, Karen E S; Borres, Magnus P; Carlsen, Kai-Håkon; Carlsen, Karin C L; Färdig, Martin; Gerdin, Sabina W; Gudmundsdóttir, Hrefna K; Haugen, Guttorm; Hedlin, Gunilla; Jonassen, Christine M; Kreyberg, Ina; Mägi, Caroline-Aleksi O; Nordhagen, Live S; Rehbinder, Eva M; Rudi, Knut; Skjerven, Håvard O; Staff, Anne C; Vettukattil, Riyas; van Hage, Marianne; Nordlund, Björn; Asarnoj, Anna.
Afiliación
  • Tedner SG; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • Söderhäll C; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Konradsen JR; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • Bains KES; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Borres MP; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • Carlsen KH; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Carlsen KCL; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
  • Färdig M; Faculty of Medicine, University of Oslo, Institute of Clinical Medicine, Oslo, Norway.
  • Gerdin SW; Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
  • Gudmundsdóttir HK; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
  • Haugen G; Faculty of Medicine, University of Oslo, Institute of Clinical Medicine, Oslo, Norway.
  • Hedlin G; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
  • Jonassen CM; Faculty of Medicine, University of Oslo, Institute of Clinical Medicine, Oslo, Norway.
  • Kreyberg I; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • Mägi CO; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Nordhagen LS; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • Rehbinder EM; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Rudi K; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
  • Skjerven HO; Faculty of Medicine, University of Oslo, Institute of Clinical Medicine, Oslo, Norway.
  • Staff AC; Faculty of Medicine, University of Oslo, Institute of Clinical Medicine, Oslo, Norway.
  • Vettukattil R; Division of Obstetrics and Gynaecology, Oslo University Hospital, Oslo, Norway.
  • van Hage M; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • Nordlund B; Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Asarnoj A; Genetic Unit, Centre for Laboratory Medicine, Østfold Hospital Trust, Kalnes, Norway.
Allergy ; 76(9): 2730-2739, 2021 09.
Article en En | MEDLINE | ID: mdl-33751598
ABSTRACT

BACKGROUND:

More knowledge about sensitization patterns in early infancy, including impact of molecular allergology, is needed to help predict future allergy development more accurately.

OBJECTIVE:

We aimed to determine the prevalence and patterns of allergic sensitization at 3 months of age, and explore possible associated factors.

METHODS:

From the Scandinavian antenatally recruited PreventADALL mother-child cohort, we included 1110 3-month infants with available serum. Sensitization was defined as s-IgE of ≥0.1 kUA /L by Phadiatop Infant® (ThermoFisher Scientific) including birch, cat, grass, dog, milk, egg, peanut and wheat. Further ImmunoCAP analyses to ovomucoid, casein, Ara h 1-3, omega-5-gliadin were performed in food extract s-IgE-positive children. Maternal sensitization was defined as s-IgE ≥ 0.35 kUA /L to Phadiatop® (inhalant allergen mix) and/or Fx5 (food allergen mix) at 18-week pregnancy.

RESULTS:

Overall 79 (7.3%) infants had specific sensitization, many with low s-IgE-levels (IQR 0.16-0.81 kUA /L), with 78 being sensitized to food extract allergens; 41 to egg, 27 to milk, 10 to peanut, and 25 to wheat. A total of 62/78 were further analysed, 18 (29%) had s-IgE to ovomucoid, casein, Ara h 1-3 and/or omega-5-gliadin. Eight infants (0.7%) were sensitized to inhalant allergens. Maternal sensitization to food allergens was associated with infant sensitization, odds ratio 3.64 (95% CI 1.53-8.68).

CONCLUSION:

Already at 3 months of age, 7% were sensitized to food, mostly without detectable s-IgE to food allergen molecules, and <1% to inhalant allergens. Maternal food sensitization was associated with infants' sensitization.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoglobulina E / Hipersensibilidad a los Alimentos Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Animals Idioma: En Revista: Allergy Año: 2021 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoglobulina E / Hipersensibilidad a los Alimentos Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Animals Idioma: En Revista: Allergy Año: 2021 Tipo del documento: Article País de afiliación: Suecia